Clinical Trial Update: The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP [NA]

View source ↗

Summary

A recruiting trial evaluating the efficacy and safety of hydroxychloroquine plus a thrombopoietin receptor agonist in ANA-positive immune thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Thrombopoietin receptor agonist (thrombopoietin receptor agonist)

Snippet

Sponsor: Yunfeng Cheng | Conditions: Immune Thrombocytopenia With Positive ANA Antibodies | NA | Status: RECRUITING